Latest publications

Quality Assurance of Stereotactic Irradiation and Survival of Patients With Head and Neck Cancer in the A GORTEC 2014-04 “OMET” Randomized Phase 2 Trial

AbstractPurposeThe OMET GORTEC 2014-04 trial showed prolonged survival with multisite Stereotactic Ablative Body...

Posted by : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Journal name : International Journal of Radiation Oncology . Biology . Physics

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials

AbstractPurposeImmunoscore (IS) and circulating tumor DNA (ctDNA) are two emerging technologies in improving...

Posted by : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Journal name : Journal of Clinical Oncology

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

AbstractPurpose: Patients with oligometastasis may have prolonged survival with multisite stereotactic ablative...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Int J Radiat Oncol Biol Phys

Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial

AbstractBackground and objective: The CABASTY study showed that more frequent administration of a lower dose of...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : European Urology Oncology

A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial

AbstractBackground: We assessed the added value of incorporating carcinoembryonic antigen (CEA) to circulating...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : The Oncologist

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer

AbstractContext and aims: Eribulin is used in taxane and anthracycline refractory HER2-negative metastatic breast...

Posted by : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Journal name : Clin Breast Cancer.

Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort Study

AbstractBackground: Stage II colon cancer (CC) exhibits considerable prognostic heterogeneous. Our objective was to...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Clin Colorectal Cancer.

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

AbstractBackground: One randomized phase III trial comparing chemotherapy (CT) with immune checkpoint inhibitors...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Eur J Cancer.

Does Kono-S Anastomosis Reduce Recurrence in Crohn's Disease Compared with Conventional Ileocolonic Anastomosis? A Nationwide Propensity Score-matched Study from GETAID Chirurgie Group [KoCoRICCO Study]

AbstractBackground and aims: Postoperative recurrence is a major concern in Crohn's disease. The Kono-S anastomosis...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : J Crohns Colitis.

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer

AbstractBackground: It is intuitively thought that early relapse is associated with poor survival after recurrence...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Eur J Cancer.

KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease

AbstractBackground: Surgical resection rates remain high in Crohn's disease (CD). Reducing postoperative recurrence...

Posted by : Dr. Dewi VERNEREY, Mr. Antoine FALCOZ
Journal name : Inflamm Bowel Dis.

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age

AbstractPurpose: Cancer patients are at risk of severe COVID-19 infection, and vaccination is recommended....

Posted by : Mr. Antoine FALCOZ
Journal name : Front Immunol

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

AbstractBackground: Trastuzumab is used, alone or in conjunction with standard chemotherapy, to treat HER2-positive...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Front Cardiovasc Med

Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?

AbstractBackground: We evaluated the value of pre-treatment positron-emission tomography-computed tomography...

Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Cancers (Basel)

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

AbstractBackground: Histological characteristics at the invasive front may reflect tumor aggressiveness;...

Posted by : Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : Annals of oncology

%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

AbstractBackground and objective: Longitudinal analysis of patient-reported outcome (PRO) data remains challenging,...

Posted by : Mr. Antoine FALCOZ
Journal name : Comput Methods Programs Biomed

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

AbstractAim: A systematic literature review of immuno-oncology trials was conducted to assess the potential impact of...

Posted by : Mr. Antoine FALCOZ,
Journal name : Qual Life Res

Feasibility of health‑related quality of life (HRQoL) assessment for cancer patients using electronic patient‑reported outcome (ePRO) in daily clinical practice

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...

Posted by : , Mr. Antoine FALCOZ, Mme. Joëlle FRITZSCH, , , Dr. Sophie PAGET-BAILLY
Journal name : Quality of Life Research

11 2020, November

Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients

AbstractBackground: Randomized controlled trials (RCTs) represent the best evidence in oncology research....

Posted by : Mr. Antoine FALCOZ, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY
Journal name : Neurooncol Pract

Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)

AbstractPatients and methods: A post hoc analysis of all pathologic reports from patients with stage III CC...

Posted by : Mme. Julie HENRIQUES, Mr. Antoine FALCOZ, Dr. Dewi VERNEREY
Journal name : J Clin Oncol